AnorMED, Inc.
Chemokine-focused company commences trading on AMEX
Published in Aging and Elder Health Week, December 11th, 2005
In addition, AnorMED has received approval for the listing of its common shares on the American Stock Exchange. AnorMED's shares began trading on the AMEX on November 4, 2005 under the stock symbol AOM.
"We believe that the listing of AnorMED's common shares on the AMEX is a positive step towards increasing our presence internationally by allowing investors to trade our shares on a major U.S. exchange," commented Michael Abrams, CEO and president of AnorMED, Inc.
AnorMED has four...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Aging and Elder Health Week
More Articles from Aging and Elder Health Week
- Axonyx, Inc.
Update provided on development of Alzheimer disease drug - CHU d'Angers
Percutaneous cholecystostomy safe and effective for high-risk patients - Case Western Reserve University School of Dental Medicine
A drug to prevent bone loss also tackles periodontal disease - Case Western Reserve University, Cleveland
Oxygen delivered through nasal cannulae often has low effective FIO2 - Cyberonics, Inc.
Medicare outpatient reimbursement rates for 2006 for VNS therapy posted - Duke University Medical Center, Durham
Recommendations for hormone replacement therapy should not increase cancer risk - More from this issue of Aging and Elder Health Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
